A study published in the current Health Affairs discusses medication therapy management. (Health Affairs Article) Prescription drugs have become perhaps the most common treatment for many chronic illnesses. Especially as people age, the number of drugs they use tends to increase. And despite the ubiquitous nature of treatment by prescription drugs, many physicians are not fully knowledgeable on managing that treatment. Underdosing, overdosing, using the wrong drug, adverse effects and non-adherence are common problems that limit the effectiveness of drug treatment. Medication therapy management is a tool that usually utilizes clinical pharmacists to manage and optimize a patient’s drug regimen. It is mandated to be offered by Medicare Advantage and Part D plans to beneficiaries that have a high level of drug spending and are on multiple drugs. The study authors focussed on the drug treatment for beneficiaries with diabetes, heart failure and COPD and sought to identify cost savings associated with medication therapy management and whether the right sets of beneficiaries were targeted. The research suggested that people who consistently adhere to a medication regimen do have lower overall spending than people who don’t have or don’t follow an optimal drug treatment regimen. The authors also suggest that expanding eligibility for medication therapy management to additional patient cohorts could result in further savings. But the study did not test actual medication therapy management program results, although other research has suggested it has positive outcomes.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
It may be investors that need the redesign. They just keep pouring money into this digital health crap despite all the losses. Redesign Health claims that it makes money by...
September 16, 2022
In truth, this seems like more money down a rathole. Google’s parent and other investors are putting a billion dollars into Google’s health arm, Verily. Apparently want to compete with...
September 12, 2022
It is like investors have learned nothing from the past two years. Even supposedly smart investors like Morgan Health, which is making a $20 million contribution to LetsGetChecked, which supposedly...
September 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace